#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Von Hippel-Lindau disease Liposarcoma metastatic Neurodegenerative disorder Paraganglion neoplasm Primary mediastinal large B-cell lymphoma Pyoderma gangrenosum Blastic plasmacytoid dendritic cell neoplasia Von Willebrand's disease Cerebral arteriovenous malformation haemorrhagic Henoch-Schonlein purpura nephritis Epileptic encephalopathy Dementia Alzheimer's type Rectal cancer White matter lesion Metastases to central nervous system More trials…

    Learn about Rare Diseases

    Castleman’s disease – Diagnostics Usher’s syndrome Usher’s syndrome – Life with Disease Idiopathic pulmonary fibrosis – Life with Disease Tuberous sclerosis complex – Trials in Disease Congenital nephrogenic diabetes insipidus – Life with Disease Rhabdomyosarcoma recurrent – Life with Disease Atypical haemolytic uraemic syndrome – Life with Disease Marfan’s syndrome – Basic Information Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ucp4 IHMA-2121908-1 Codeine Phosphate Ceftriaxone Sodium Pelareorep Roxithromycin Nacystelyn GSKVX000000070250 AZD0516 Water For Injection Naproxen VORMATRIGINE Ly3556050 LTG-001 Setrusumab Fluorescein Sodium Triptorelin Regtivex Ondansetron Hydrochloride Metyrapone Bp More therapies…

    Learn about Your Condition

    Testicular leiomyosarcoma Alveolar proteinosis Endocarditis Addison's disease Prostate cancer Myotonia Bacterial infection Laparotomy Amyloidosis Duchenne muscular dystrophy Tricuspid valve disease Dyspepsia Renal failure Diabetic foot Agitation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Systemic lupus erythematosus

  • Phase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Entecavir
    • Ianalumab
    • Tenofovir Disoproxil
    Bulgaria Czechia Hungary Poland Portugal Slovakia +1

  • Evaluation of Long-term Safety and Efficacy of Enpatoran in Subacute Cutaneous, Discoid, and Systemic Lupus Erythematosus Post-WILLOW Study Completion

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cutaneous lupus erythematosus
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Enpatoran
    Bulgaria Greece Poland Romania Spain

  • Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Nonbiologic Standard of Care: A Phase 3 Randomized Controlled Trial

    Not recruiting

    3 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Litifilimab
    Bulgaria France Greece Poland Spain Sweden

  • Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Standard Nonbiologic Lupus Care: A Phase 3 Randomized Controlled Trial

    Not recruiting

    3 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Litifilimab
    Belgium Czechia Germany Hungary Italy The Netherlands +1

  • Study on the Effects of Belimumab and Rituximab for Patients with Severe Systemic Lupus Erythematosus

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Glomerulonephritis
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Belimumab
    • Rituximab
    The Netherlands

  • Study on the Effects of Ianalumab in Adults with Rheumatoid Arthritis, Systemic Lupus Erythematosus, or Sjögren’s Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Dry eye
    • Sjogren’s syndrome
    • Rheumatoid arthritis
    Investigated Drugs:
    • Entecavir
    • Ianalumab
    • Tenofovir Disoproxil
    Czechia Germany Hungary Italy The Netherlands Poland +1
Previous Page
1 … 4 5 6 7 8 … 10
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!